ALDEYRA THERAPEUTICS, INC. (ALDX) Free cash flow 2016–2023
ALDEYRA THERAPEUTICS, INC. (ALDX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$30.3MFY2023 · since FY2016: -$15.2M → -$30.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -$30.3M | +46.5% |
| FY2022 | -$56.7M | -33.1% |
| FY2021 | -$42.6M | — |
| FY2019 | -$45.0M | -49.4% |
| FY2018 | -$30.1M | -56.5% |
| FY2017 | -$19.2M | -27.0% |
| FY2016 | -$15.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice